Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: TENX) | Delayed: 1.97 +0.11 (5.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.86 | 52 Week High | $3.40 | |||
| Open | $1.92 | 52 Week Low | $1.34 | |||
| Day High | $1.97 | P/E | N/A | |||
| Day Low | $1.85 | EPS | $0.00 | |||
| Volume | 2,948,221 | |||||

